X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38180) 38180
Newspaper Article (11691) 11691
Publication (4342) 4342
Newsletter (1683) 1683
Book Chapter (588) 588
Book Review (367) 367
Magazine Article (91) 91
Book / eBook (64) 64
Conference Proceeding (54) 54
Trade Publication Article (42) 42
Dissertation (34) 34
Web Resource (20) 20
Report (16) 16
Government Document (15) 15
Data Set (6) 6
Paper (4) 4
Reference (4) 4
Journal / eJournal (3) 3
Streaming Video (2) 2
Microfilm (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gram-negative bacteria (27738) 27738
humans (21160) 21160
bacteria (18044) 18044
index medicus (15721) 15721
microbiology (11736) 11736
infections (9689) 9689
animals (8805) 8805
male (8580) 8580
infectious diseases (8498) 8498
female (8461) 8461
research (7187) 7187
antibiotics (6567) 6567
gram-negative bacterial infections - microbiology (5890) 5890
anti-bacterial agents - pharmacology (5889) 5889
microbial sensitivity tests (5616) 5616
gram-negative bacteria - drug effects (5550) 5550
middle aged (5162) 5162
bacterial infections (4973) 4973
adult (4964) 4964
immunology (4945) 4945
anti-bacterial agents - therapeutic use (4250) 4250
escherichia-coli (4187) 4187
aged (4149) 4149
drug resistance (4094) 4094
gram-negative bacteria - isolation & purification (3819) 3819
health aspects (3717) 3717
pharmacology & pharmacy (3707) 3707
pathogens (3669) 3669
gram-negative bacterial infections - drug therapy (3459) 3459
proteins (3433) 3433
infection (3342) 3342
analysis (3246) 3246
e coli (3236) 3236
medicine (3208) 3208
research article (3197) 3197
epidemiology (3167) 3167
antimicrobial agents (3124) 3124
gram-positive bacteria - drug effects (2938) 2938
pseudomonas-aeruginosa (2726) 2726
risk factors (2645) 2645
life sciences (2514) 2514
adolescent (2353) 2353
genes (2330) 2330
mice (2264) 2264
drug resistance in microorganisms (2253) 2253
virulence (2235) 2235
mortality (2224) 2224
gram-negative bacterial infections - epidemiology (2138) 2138
researchers (2107) 2107
biochemistry & molecular biology (2098) 2098
resistance (2042) 2042
drug resistance, bacterial (2036) 2036
molecular sequence data (2006) 2006
identification (2004) 2004
retrospective studies (1979) 1979
gene expression (1974) 1974
child (1917) 1917
science (1915) 1915
multidisciplinary sciences (1904) 1904
gram-negative bacterial infections - diagnosis (1875) 1875
nosocomial infections (1872) 1872
bacteremia (1851) 1851
bacteriology (1824) 1824
pneumonia (1812) 1812
biology (1811) 1811
sepsis (1806) 1806
gram-negative bacterial infections - veterinary (1790) 1790
veterinary sciences (1790) 1790
gram-negative bacilli (1789) 1789
medical research (1771) 1771
hospitals (1760) 1760
aged, 80 and over (1745) 1745
gram-positive bacteria - isolation & purification (1722) 1722
bacterial proteins - genetics (1714) 1714
cross infection - microbiology (1693) 1693
physiological aspects (1680) 1680
drug resistance, multiple, bacterial (1618) 1618
prevalence (1612) 1612
antimicrobial resistance (1574) 1574
gram-positive bacteria (1542) 1542
bacterial proteins - metabolism (1529) 1529
studies (1527) 1527
biofilms (1506) 1506
pseudomonas aeruginosa (1496) 1496
salmonella (1494) 1494
escherichia coli (1488) 1488
treatment outcome (1468) 1468
genetic aspects (1455) 1455
child, preschool (1447) 1447
genomics (1416) 1416
bacteremia - microbiology (1414) 1414
antibacterial agents (1405) 1405
pediatrics (1390) 1390
pathogenesis (1385) 1385
laboratories (1383) 1383
infant (1365) 1365
prospective studies (1354) 1354
mutation (1346) 1346
genomes (1342) 1342
amino acid sequence (1330) 1330
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (44) 44
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
UofT at Mississauga - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
Victoria University E.J. Pratt - Stacks (3) 3
Robarts - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Robarts - Government Pubs (1) 1
St. Michael's Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49812) 49812
Spanish (556) 556
French (416) 416
Russian (319) 319
German (242) 242
Japanese (223) 223
Chinese (213) 213
Polish (111) 111
Italian (83) 83
Turkish (66) 66
Portuguese (56) 56
Dutch (37) 37
Korean (36) 36
Romanian (35) 35
Czech (25) 25
Bulgarian (22) 22
Danish (17) 17
Norwegian (15) 15
Ukrainian (15) 15
Hungarian (14) 14
Finnish (13) 13
Croatian (11) 11
Swedish (10) 10
Persian (7) 7
Hebrew (5) 5
Arabic (2) 2
Icelandic (2) 2
Afrikaans (1) 1
Greek (1) 1
Indonesian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015, ISBN 1783463503, 248 p., 16 unnumbered p.s of plates
Book
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
2011, ISBN 0752428292, 224
Book
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2013, Volume 34, Issue 9, pp. 940 - 946
Objective. Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge... 
Hospitalization rates | Pathogens | Databases | Original Article | Escherichia coli | Urinary tract infections | Hospitalization | Infections | Carbapenems | Klebsiella pneumoniae | Enterobacteriaceae | MORTALITY | INFECTIOUS DISEASES | SINGLE-CENTER EXPERIENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORAL-THERAPY | PYELONEPHRITIS | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ANTIBIOTIC-TREATMENT | PNEUMONIA | NOSOCOMIAL INFECTIONS | PATHOGENS | Escherichia coli Infections - drug therapy | United States - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Drug Resistance, Bacterial | Escherichia coli Infections - microbiology | Hospitalization - statistics & numerical data | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Gram-Negative Bacterial Infections - microbiology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Klebsiella Infections - epidemiology | Pseudomonas Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Cross Infection - epidemiology
Journal Article
2009, ISBN 9780807833100, xii, 384 p., [12] p. of plates
Book
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, Issue suppl 2, pp. S69 - S78
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for... 
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | NECROTIZING FASCIITIS | CARE-ASSOCIATED INFECTIONS | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | STREPTOCOCCAL INFECTIONS | STAPHYLOCOCCUS-AUREUS INFECTIONS | SURGICAL SITE INFECTION | EPIDEMIOLOGY | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use
Journal Article
2001, ISBN 1555812139, xvi, 608
This new volume offers a comprehensive survey of Helicobacter biology, ranging from fundamental bacteriology through energy metabolism and synthetic pathways,... 
Helicobacter pylori | Helicobacter pylori infections
Book
American Journal of Emergency Medicine, ISSN 0735-6757, 2016, Volume 35, Issue 4, pp. 579 - 583
Abstract Objective The aim of this study was to evaluate procalcitonin (PCT) diagnostic accuracy in discriminating gram-negative (GN) from gram-positive (GP)... 
Emergency | Positive blood culture | Procalcitonin | Bacterial species | Gram-positive bacteria | Sepsis | Gram-negative bacteria | Infection sites | DIAGNOSIS | MANAGEMENT | ANTIBIOTIC USE | GUIDELINES | MARKERS | CALCITONIN | EMERGENCY MEDICINE | SEPTIC SHOCK | SERUM PROCALCITONIN | RESPIRATORY-TRACT INFECTIONS | Enterococcus faecalis | Escherichia coli | Humans | Middle Aged | Escherichia coli Infections - blood | Male | Acinetobacter Infections - blood | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Endocarditis, Bacterial - blood | Staphylococcus haemolyticus | Burkholderia cepacia | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Klebsiella Infections - blood | Burkholderia Infections - microbiology | Staphylococcal Infections - blood | Staphylococcus aureus | Acinetobacter Infections - microbiology | Pneumonia, Bacterial - blood | Calcitonin - blood | Emergency Service, Hospital | Intensive Care Units | Pneumonia, Bacterial - microbiology | Escherichia coli Infections - microbiology | Biomarkers - blood | Klebsiella Infections - microbiology | Gram-Positive Bacterial Infections - blood | Enterococcus faecium | Staphylococcus hominis | Acinetobacter baumannii | Urinary Tract Infections - blood | Staphylococcus epidermidis | Catheter-Related Infections - blood | Catheter-Related Infections - microbiology | Gram-Negative Bacterial Infections - blood | Aged | Burkholderia Infections - blood | Klebsiella pneumoniae | Bacteria | Health aspects | Medical research | Medical examination | Microbiology | Emergency medicine | Analysis | Endocarditis | Medicine, Experimental | Urinary tract infections | Blood | Klebsiella | Multiple sclerosis | Intensive care | Pneumonia | Disease | Laboratories | Lung cancer | Infections | Arthritis | Family medical history | Urinary tract | Microorganisms | Burkholderia | Lupus | Pathogens | Bacterial infections | Medical instruments | Patients | Thyroid cancer | Biomarkers | Cutoffs | Diagnostic systems
Journal Article
2006, The Greenwood Press "Daily life through history" series, ISBN 0313332975, xii, 326
Book
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 02/2015, Volume 16, Issue 2, pp. 159 - 177
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Hepatology, ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in cirrhosis are poorly known. This work was a prospective evaluation... 
PERITONITIS | LIVER-CIRRHOSIS | ACQUIRED INFECTIONS | ESCHERICHIA-COLI | ACQUISITION | RESISTANCE | HEPATORENAL-SYNDROME | SEPSIS | NORFLOXACIN PROPHYLAXIS | GASTROENTEROLOGY & HEPATOLOGY | KLEBSIELLA-PNEUMONIAE | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology
Journal Article